Anacor Pharmaceuticals Inc (ANAC)

NASDAQ
99.06
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.01/99.25
  • Day's Range:
    99.06 - 99.06

ANAC Overview

Prev. Close
99.06
Day's Range
99.06-99.06
Revenue
84.63M
Open
99.23
52 wk Range
0-0
EPS
-1.45
Volume
0
Market Cap
4.5B
Dividend (Yield)
0.00
(N/A)
Average Vol. (3m)
3,501,050
P/E Ratio
-
Beta
1.55
1-Year Change
0%
Shares Outstanding
45,378,156
Next Earnings Date
-
What is your sentiment on Anacor Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Anacor Pharmaceuticals Inc Company Profile

Employees
110

Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. It markets KERYDIN (tavaborole) topical solution for the treatment of onychomycosis of the toenails. The company’s lead product candidate is crisaborole topical ointment, 2%, anti-inflammatory phosphodiesterase-4 inhibitor, which is in Phase III clinical trials for the treatment of mild-to-moderate atopic dermatitis and psoriasis. It is also developing AN3365, an antibiotic product candidate for the treatment of infections caused by Gram-negative bacteria. The company has collaboration agreements with the Global Alliance for Livestock Veterinary Medicines to develop drug candidates for the treatment and prevention of African trypanosomiasis in cattle; Drugs for Neglected Diseases initiative to develop new therapeutics for human African trypanosomiasis (TB), visceral leishmaniasis, and Chagas disease; GlaxoSmithKline LLC for tuberculosis; Eli Lilly and Company for an animal health indication; and The Bill & Melinda Gates Foundation for filarial worm diseases, TB, and cryptosporidiosis. The company was formerly known as AnaMax, Inc. and changed its name to Anacor Pharmaceuticals, Inc. in October 2002. Anacor Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Palo Alto, California. As of June 23, 2016, Anacor Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.